Dr. Sakuraba focuses on inflammatory bowel disease. His research projects include advancing the effectiveness of combination therapy with an immunomodulator in anti-TNF treated IBD patients; optimization of novel biologic/immunomodulatory agents to treat refractory IBD; and analyzing the long term outcome of patients with microscopic colitis. His work has been published in numerous journals, including Gastroenterology and Inflammatory Bowel Diseases.
Dr. Sakuraba earned his medical degree at Keio University School of Medicine in Tokyo, Japan. He completed his residency at Keio University Hospital in Tokyo, where he completed a fellowship. He also completed a fellowship at University of Chicago Medicine.
More articles on GI/endoscopy:
3 GI physicians in the news – Oct. 16, 2015
ACG elects Dr. Kenneth DeVault president: 5 things to know
5 most-read GI/endoscopy stories – Week of Oct 12 to Oct. 16
